beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
|
|
beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
bronchoconstrictor agent
A drug which causes a narrowing of the lumen of a bronchus or bronchiole.
hematologic agent
Drug that acts on blood and blood-forming organs and those that affect the hemostatic system.
vasodilator agent
A drug used to cause dilation of the blood vessels.
|
|
(2R)-2-acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate
|
(R)-7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphapentacosan-1-aminium hydroxide inner salt 4-oxide
|
ChEBI
|
1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine
|
LIPID MAPS
|
1-O-hexadecyl PAF
|
ChEBI
|
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine
|
UniProt
|
1-O-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
|
ChemIDplus
|
1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosophocholine
|
ChemIDplus
|
1-O-hexadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine
|
ChemIDplus
|
1-O-hexadecyl-platelet-activating factor
|
ChemIDplus
|
C16 PAF
|
ChEBI
|
C16-PAF
|
ChEBI
|
C16:0 PAF
|
ChEBI
|
PAF
|
ChEBI
|
Platelet activating factor
|
ChemIDplus
|
platelet-activating factor
|
ChEBI
|
platelet-activating factor C16
|
ChemIDplus
|